Exclusive: Dicerna CEO Discusses Financials And Institutional Investors
February 16, 2017 at 09:40 AM EST
Benzinga recently had the chance to chat with Dicerna Pharmaceuticals Inc (NASDAQ: DRNA)’s CEO Douglas M. Fambrough, Ph.D., who ...